A prospective study of costs associated to the evaluation of non-steroidal anti-inflammatory hypersensitivity reactions

Allergy. 2020 Jun;75(6):1495-1497. doi: 10.1111/all.14169. Epub 2020 Jan 17.

Authors

Miriam Sobrino-García¹, Francisco J Muñoz-Bellido^{1

2

3}, Esther Moreno^{1

2

3

4}, Eva Macías^{1

2

3}, María-Teresa Gracia-Bara^{1

2}, Elena Laffond^{1

2

3}, Milagros Lázaro-Sastre¹, Cristina Martín-García¹, Sonia de Arriba-Méndez^{1

2

3}, María-Valle Campanón-Toro¹, Alicia Gallardo-Higueras¹, Ignacio Dávila^{1

2

3

4}

Affiliations

¹ Allergy Service, University Hospital of Salamanca, Salamanca, Spain.
² Institute for Biomedical Research of Salamanca, IBSAL, Salamanca, Spain.
³ Department of Biomedical and Diagnostic Sciences, Faculty of Medicine, University of Salamanca, Salamanca, Spain.
⁴ Asthma, Allergic and Adverse Reactions (ARADyAL) Network for Cooperative Research in Health of Instituto de Salud Carlos III, Salamanca University Hospital, Salamanca, Spain.

PMID: 31891420
DOI: 10.1111/all.14169

No abstract available

Publication types

Letter

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal* / adverse effects
Drug Hypersensitivity* / diagnosis
Humans
Prospective Studies

Substances

Anti-Inflammatory Agents, Non-Steroidal